Treace Medical Concepts (TMCI) Accumulated Expenses (2020 - 2026)

Treace Medical Concepts has reported Accumulated Expenses for 7 years, with the latest figure at $6.0 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 225.6% year-over-year to $6.0 million; the trailing twelve-month figure through Mar 2026 stood at $6.0 million (up 225.6% YoY), and the FY2025 full-year result was $5.8 million, up 156.04% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $6.0 million, up from $5.8 million in the prior quarter.
• The five-year high for Accumulated Expenses was $8.9 million in Q3 2023, with the low at $403000.0 in Q3 2024.
• Historically, Accumulated Expenses has averaged $4.9 million across 5 years, with a median of $5.4 million in 2023.
• Annual changes were most pronounced in 2023 — Accumulated Expenses surged 1732.28% — and 2024, when it tumbled 95.49%.
• Treace Medical Concepts' Accumulated Expenses stood at $412000.0 in 2022, then surged by 1732.28% to $7.5 million in 2023, then slumped by 70.08% to $2.3 million in 2024, then surged by 156.04% to $5.8 million in 2025, then climbed by 3.35% to $6.0 million in 2026.
• The last three Accumulated Expenses figures came in at $6.0 million (Q1 2026), $5.8 million (Q4 2025), and $7.3 million (Q3 2025), per Business Quant data.